A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases

Citations Over TimeTop 20% of 2012 papers

Abstract

We present a straightforward process for the discovery of novel back pocket-binding fragment molecules against protein tyrosine kinases. The approach begins by screening against the nonphosphorylated target kinase with subsequent counterscreening of hits against the phosphorylated enzyme. Back pocket-binding fragments are inactive against the phosphorylated kinase. Fragment molecules are of insufficient size to span both regions of the ATP binding pocket; thus, the outcome is binary (back pocket-binding or hinge-binding). Next, fragments with the appropriate binding profile are assayed in combination with a known hinge-binding fragment and subsequently with a known back pocket-binding fragment. Confirmation of back pocket-binding by Yonetani-Theorell plot analysis progresses candidate fragments to crystallization trials. The method is exemplified by a fragment screening campaign against vascular endothelial growth factor receptor 2, and a novel back pocket-binding fragment is presented.

Related Papers

• → Eph receptors and ephrin ligands: embryogenesis to tumorigenesis(2000)297 cited
• → Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases(2006)251 cited
• → TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system(2013)72 cited
• → Characterisation of five novel zebrafish Eph-related receptor tyrosine kinases suggests roles in patterning the neural plate(1997)37 cited
• Increased Expression of MET and RON Receptor Tyrosine Kinases in Canine Cutaneous Melanotic Tumor(2009)